Table 3. Relative perfusion and resistance changes.
| All (n = 12) | Diabetes (n = 5) | Non Diabetes (n = 7) | p+ | |
|---|---|---|---|---|
| ∆QI (%) | ||||
| t2 | -7.7 ± 8.1 | -9.6 ± 7.5 | -6.4 ± 8.8 | 0.52 |
| t3 | -12.0 ± 11.3 | -15.2 ± 10.7 | -9.7 ± 11.9 | 0.44 |
| t4 | -15.1 ± 10.5 | -16.8 ± 13.7 | -13.9 ± 8.5 | 0.67 |
| p* | 0.11 | 0.08 | 0.38 | |
| ∆RI (%) | ||||
| t2 | 6.1 ± 11.9 | 11.2 ± 13.2 | 2.5 ± 10.3 | 0.22 |
| t3 | 13.9 ± 20.9 | 26.3 ± 23.2 | 5.1 ± 14.9 | 0.08 |
| t4 | 19.2 ± 18.8 | 29.6 ± 21.3 | 11.8 ± 13.9 | 0.11 |
| p* | 0.01 | 0.02 | 0.29 |
∆QI: change of hepato-splanchnic blood flow index at times t 2, t 3, and t 4 relative to baseline at t1; ∆RI: change of hepato-splanchnic vascular resistance index at times t 2, t 3, and t 4 relative to baseline at t1; p*: probability for single factor variance analyses with repeated measurement; p +: probability for two-sample t-test for comparison between diabetics and non-diabetics